Detailed text transcripts for TV channel - CNN - 20180305:02:51:00
For add non-small cell lung cancer, previously treated with platinum-based chemotherapy, including those with an abnormal alk or egfr gene whove tried an fda-approved targeted therapy, who wouldnt want a chance for another...? whod say no to a...? who wouldnt want a chance to live longer. opdivo (nivolumab). over 40,000 patients have been prescribed opdivo immunotherapy. opdivo can cause your immune system to attack normal organs and tissues in your body and affect how they work. this may happen...
Source: news source